MediPharm Labs Corp. (TSX:LABS)
Canada flag Canada · Delayed Price · Currency is CAD
0.0650
0.00 (0.00%)
At close: Mar 20, 2026

MediPharm Labs Cash Flow Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-8.03-10.69-13.08-29.98-54.8-67.11
Depreciation & Amortization
1.832.62.522.875.6310.81
Stock-Based Compensation
0.280.982.032.872.42.68
Other Adjustments
-0.270.61-7.251.9327.2-1.33
Change in Receivables
-1.02-1.566.293.625.93-2.09
Changes in Inventories
1.420.83.11-0.12.4929.41
Changes in Accounts Payable
0.191.87-5.171.49-8.11-4.57
Changes in Accrued Expenses
-1.830.410.15-0.521.090.08
Changes in Income Taxes Payable
--0.13-0.014.26-4.49
Changes in Other Operating Activities
-0.631.792.381.750.7-1.16
Operating Cash Flow
-7.01-4.86-12.34-16.07-13.21-37.77
Capital Expenditures
-0.14-0.15-0.47-0.86-0.78-7.5
Sale of Property, Plant & Equipment
4.720.572.080.010.820.06
Purchases of Investments
------0
Proceeds from Business Divestments
--4.256.01--
Other Investing Activities
--1.01---
Investing Cash Flow
4.580.416.875.160.04-7.45
Long-Term Debt Issued
0.530.81.071.34--
Long-Term Debt Repaid
-0.72-2.92-1.76-0.82-2.63-13.65
Net Long-Term Debt Issued (Repaid)
-0.45-2.12-0.70.52-2.63-13.65
Issuance of Common Stock
-0.01--30.9241.45
Net Common Stock Issued (Repurchased)
-0.01--30.9241.45
Other Financing Activities
0.130.260.330.27-0.48-1.38
Financing Cash Flow
-0.08-1.85-0.370.827.826.42
Effect of Exchange Rate Changes on Cash and Cash Equivalents
00-0.330.15-0.430.08
Net Cash Flow
-2.51-6.29-6.16-9.9714.2-18.71
Free Cash Flow
-7.15-5.02-12.81-16.93-14-45.28
FCF Margin
-15.51%-11.95%-38.75%-76.56%-64.47%-125.72%
Free Cash Flow Per Share
-0.02-0.01-0.04-0.06-0.06-0.33
Levered Free Cash Flow
-7.39-5.5-11.13-24.83-52.16-57.43
Unlevered Free Cash Flow
-7.4-3.5-15.98-24.91-43.54-55.03
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.